Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
84 /100
CRITICAL RISK
Score updated Aug 28, 2026

SONM — DNA X, Inc. Dilution Risk Tracker

Track SONM dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SONM — Get alerts when the score changes →

As of August 28, 2026, DNA X, Inc. (SONM) has a DilutionWatch DilutionScore of 84/100, rated CRITICAL dilution risk. DNA X, Inc. has a market capitalization of $6.56M, 1.49M shares outstanding, 3 institutional holders tracked. Stored dilution-related fields include 155.3K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
95
📊 Float Risk
25
⚠️ Warrant Exposure
50
🔄 Convertible Debt
60

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 42%
💰 Capital Raise model 55%
• Critical: only 0.8 months cash remaining
🔁 Convertible Conversion model 40%
• Significant convertible debt: 18% potential dilution
• Elevated convertible risk (60/100)
🔄 Reverse Split model est. 15%
• Only 1 months cash — financial pressure
🔔 Track SONM — Get forecast alerts →

Market Data

Market Cap$6.56M
Shares Outstanding1.49M
Float1.21M
Cash$1.20M
Debt$1.32M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 6.3% shares (2026Q1 vs prior)
3 institutional holders · 320 shares
#1 MORGAN STANLEY 300 shares
#2 BARCLAYS PLC 18 shares
#3 DANSKE BANK A/S 2 shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest59.4K
Days to Cover3.8
% of Float4.9%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2025-12-15
xbrl XBRL WARRANT 2025-05-12
8-K/A 8K EVENT 2026-03-02
3 FORM3 2026-02-20
4 INSIDER TRANSACTION 2026-02-10
Full SEC filing analysis available with free account

Recent News

No recent news

Factual SONM Dilution Snapshot

DNA X, Inc. (SONM) has a DilutionScore of 84/100, rated Critical dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track SONM Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SONM — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for SONM
SONM FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.